| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2024-12-03 | Herskowitz Neil Director | Sale | -23 | -19.17%97 | $2.00 | $46 | View SEC filing | |
| 2024-11-07 | KRANZLER JAY D Director | Sale | -61 | -9.84%559 | $2.24 | $137 | View SEC filing | |
| 2024-10-01 | KRANZLER JAY D Director | Purchase | +500 | +416.67%620 | $2.50 | $1,250 | View SEC filing | |
| 2023-12-13 | Davidow Robert L 10% Owner | Sale | -617,000 | -33.59%1,219,800 | $0.14 | $86,560 | View SEC filing | |
| 2023-09-12 | ROSENWALD LINDSAY A MD Director | Purchase | +348,675 | +6178.89%354,318 | $0.72 | $251,046 | View SEC filing | |
| 2023-09-12 | Fortress Biotech, Inc. 10% Owner | Purchase | +418,410 | +68.15%1,032,390 | $0.72 | $301,255 | View SEC filing | |
| 2022-10-13 | InvaGen Pharmaceuticals, Inc. 10% Owner | Sale | -388,888 | -100.00%0 | $7.71 | $2,999,882 | View SEC filing | |
| 2021-09-15 | Vazzano Joseph Walter Chief Financial Officer | Sale | -7,160 | -9.89%65,252 | $1.62 | $11,599 | View SEC filing | |
| 2021-05-07 | Herskowitz Neil Director | Purchase | +2,500 | +1.89%134,724 | $3.99 | $9,975 | View SEC filing | |
| 2020-08-21 | Vazzano Joseph Walter Chief Financial Officer | Sale | -3,840 | -6.27%57,412 | $12.13 | $46,579 | View SEC filing | |
| 2020-03-10 | Vazzano Joseph Walter Chief Financial Officer | Purchase | +3,389 | +5.86%61,252 | $7.96 | $26,982 | View SEC filing | |
| 2020-03-02 | Herskowitz Neil Director | Purchase | +2,561 | +2.14%122,224 | $8.23 | $21,086 | View SEC filing | |
| 2020-02-25 | Vazzano Joseph Walter Chief Financial Officer | Purchase | +1,200 | +2.12%57,863 | $9.09 | $10,908 | View SEC filing | |
| 2020-02-25 | Herskowitz Neil Director | Purchase | +10,000 | +9.12%119,663 | $9.31 | $93,100 | View SEC filing | |
| 2019-09-16 | Ingram Elizabeth Garrett Director | Purchase | +16,000 | +100.00%16,000 | $6.27 | $100,320 | View SEC filing | |
| 2019-08-12 | Vazzano Joseph Walter Chief Financial Officer | Sale | -4,688 | -7.64%56,663 | $5.59 | $26,204 | View SEC filing | |
| 2019-06-19 | Herskowitz Neil Director | Purchase | +5,000 | +5.28%99,663 | $5.86 | $29,300 | View SEC filing | |
| 2019-04-15 | Herskowitz Neil Director | Purchase | +1,000 | +1.07%94,663 | $4.52 | $4,520 | View SEC filing | |
| 2019-03-29 | Herskowitz Neil Director | Purchase | +2,000 | +2.18%93,663 | $5.11 | $10,220 | View SEC filing | |
| 2019-02-25 | Herskowitz Neil Director | Purchase | +5,000 | +5.77%91,663 | $5.46 | $27,300 | View SEC filing | |
| 2019-02-06 | Herskowitz Neil Director | Purchase | +8,850 | +11.37%86,663 | $5.88 | $52,045 | View SEC filing | |
| 2019-02-01 | Herskowitz Neil Director | Purchase | +650 | +0.84%77,813 | $5.91 | $3,842 | View SEC filing | |
| 2019-01-30 | Herskowitz Neil Director | Purchase | +10,000 | +14.89%77,163 | $5.90 | $58,999 | View SEC filing | |
| 2018-12-12 | Paley Jeffrey Director | Purchase | +15,000 | +23.20%79,663 | $5.24 | $78,554 | View SEC filing | |
| 2018-06-12 | ROSENWALD LINDSAY A MD Director | Purchase | +50,000 | +250.00%70,000 | $4.28 | $214,143 | View SEC filing |
1-25 of 30
